Heartflow (NASDAQ:HTFL) Sets New 12-Month High - Should You Buy?

Key Points

• Heartflow (NASDAQ:HTFL) reached a new 52-week high at $36.99 during trading, up from a previous close of $35.92.
• Brokerages have given the stock a mixed rating with four analysts rating it as a Buy and two as a Hold, leading to an average rating of "Moderate Buy" and a consensus target price of $36.60.
• Despite a revenue performance showing $43.42 million for the quarter, Heartflow missed earnings expectations with an EPS of ($1.46), significantly below the consensus estimate.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $36.99 and last traded at $36.99, with a volume of 44847 shares. The stock had previously closed at $35.92.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on HTFL. Zacks Research upgraded Heartflow to a "hold" rating in a research report on Wednesday, September 3rd. Stifel Nicolaus began coverage on Heartflow in a research report on Tuesday, September 2nd. They issued a "buy" rating and a $35.00 target price for the company. Wall Street Zen upgraded Heartflow to a "hold" rating in a research report on Saturday, August 16th. Piper Sandler began coverage on Heartflow in a research report on Tuesday, September 2nd. They issued an "overweight" rating and a $38.00 target price for the company. Finally, JPMorgan Chase & Co. began coverage on Heartflow in a research report on Tuesday, September 2nd. They issued an "overweight" rating and a $36.00 target price for the company. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $36.60.

Heartflow Price Performance

Heartflow (NASDAQ:HTFL - Get Free Report) last released its quarterly earnings data on Friday, September 19th. The company reported ($1.46) EPS for the quarter, missing the consensus estimate of ($0.20) by ($1.26). The company had revenue of $43.42 million for the quarter, compared to the consensus estimate of $43.20 million.

About Heartflow

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.